HK40077365A - Anti-cd371 antibodies and uses thereof - Google Patents

Anti-cd371 antibodies and uses thereof Download PDF

Info

Publication number
HK40077365A
HK40077365A HK62023067342.3A HK62023067342A HK40077365A HK 40077365 A HK40077365 A HK 40077365A HK 62023067342 A HK62023067342 A HK 62023067342A HK 40077365 A HK40077365 A HK 40077365A
Authority
HK
Hong Kong
Prior art keywords
antibodies
Prior art date
Application number
HK62023067342.3A
Other languages
Chinese (zh)
Inventor
Anthony DANIYAN
Renier J. BRENTJENS
Ivo C. Lorenz
Mary Ann POHL
Original Assignee
Memorial Sloan-Kettering Cancer Center
Tri-Institutional Therapeutics Discovery Institute, Inc.
Sloan-Kettering Institute For Cancer Research
Memorial Hospital For Cancer And Allied Diseases
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan-Kettering Cancer Center, Tri-Institutional Therapeutics Discovery Institute, Inc., Sloan-Kettering Institute For Cancer Research, Memorial Hospital For Cancer And Allied Diseases filed Critical Memorial Sloan-Kettering Cancer Center
Publication of HK40077365A publication Critical patent/HK40077365A/en

Links

HK62023067342.3A 2019-09-13 2020-09-11 Anti-cd371 antibodies and uses thereof HK40077365A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962900118P 2019-09-13
US201962936913P 2019-11-18

Publications (1)

Publication Number Publication Date
HK40077365A true HK40077365A (en) 2023-03-03

Family

ID=

Similar Documents

Publication Publication Date Title
EP3997127A4 (en) Dll3-targeting antibodies and uses thereof
CA3265597A1 (en) Anti-lilrb1 antibody and uses thereof
EP4001308A4 (en) Anti-tigit antibodies and application thereof
EP3774888A4 (en) Anti-phf-tau antibodies and uses thereof
AU2019351294B2 (en) Anti-human VSIG4 antibodies and uses thereof
EP3976657A4 (en) Anti-trka antibodies and uses thereof
EP4041403A4 (en) Anti-kir3dl3 antibodies and uses thereof
EP4051713A4 (en) Immunomodulatory anti-cd73 antibodies and uses thereof
EP3894439A4 (en) Anti-periostin antibodies and uses thereof
EP4071171A4 (en) Anti-tm4sf4 antibody and use thereof
CA3279395A1 (en) Galectin-7-specific monovalent antibodies and uses thereof
GB201902590D0 (en) Antibodies and uses thereof
EP4025611A4 (en) Anti-cxcr2 antibodies and uses thereof
EP3983435A4 (en) Anti-talen antibodies and uses thereof
HK40077274A (en) Anti-kir3dl3 antibodies and uses thereof
HK40071706A (en) Anti-il-27 antibodies and uses thereof
HK40075749A (en) Anti-ceacam antibodies and uses thereof
HK40077365A (en) Anti-cd371 antibodies and uses thereof
HK40075697A (en) Anti-mglur5 antibodies and uses thereof
HK40078058A (en) Anti-trem-1 antibodies and uses thereof
HK40064723A (en) Dll3-targeting antibodies and uses thereof
HK40073178A (en) Anti-talen antibodies and uses thereof
HK40069467A (en) Anti-galectin-9 antibodies and uses thereof
HK40069770A (en) Anti-hla-c antibodies and uses thereof
HK40064372A (en) Anti-tauc3 antibodies and uses thereof